Switpride MP2 Tablet ER
Marketer
Lifecare Neuro Products Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Switpride MP2 Tablet ER
Diapride ER is a dual-action tablet formulated to manage blood glucose. In conjunction with diet and exercise, it aids adults with type 2 diabetes in achieving better glycemic control. Its mechanism enhances insulin effectiveness, resulting in reduced blood sugar. Adhere strictly to your physician's prescribed dosage and regimen for Diapride ER; taking it with food minimizes gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed one and resume your usual schedule. Never double the dose; overdose can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing Diapride ER, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption to mitigate potential adverse effects.
Primary Ingredients of Switpride MP2 Tablet ER
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Switpride MP2 Tablet ER
Managing type 2 diabetes
Major Benefits of Switpride MP2 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Switpride MP2 Tablet ER with a meal.
Common Side effects of Switpride MP2 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Switpride MP2 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Switpride MP2 Tablet ER whole; avoid chewing, crushing, or breaking it. It should be administered with food.
How Switpride MP2 Tablet ER works:
Switpride MP2 Extended-Release tablets combine the actions of three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. This triple-drug approach offers enhanced blood glucose management when single or dual therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity within the body.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Switpride MP2 Tablet ER is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Switpride MP2 Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Switpride MP2 tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Switpride MP2 Extended-Release Tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Switpride MP2 Extended-Release Tablets are contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Switpride MP2 Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is advised. Switpride MP2 Tablet ER is contraindicated in individuals with severe liver disease.
What if you forget to take Switpride MP2 Tablet ER :
Should you forget a dose of Switpride MP2 Tablet ER, take it immediately if you remember. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Switpride MP2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes medication |



